학술논문
Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model.
Document Type
Article
Author
Source
International Journal of Molecular Medicine; 2015, Vol. 36 Issue 3, p767-775, 9p
Subject
Language
ISSN
11073756